The Trustees of the University of Pennsylvania, through its Clinical Practices division, was awarded a $556,002 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) to investigate the protective role of the cytokine interleukin-27 (IL-27) in preventing immune dysregulation and congenital infection at the maternal-fetal interface. The project aims to define the immune regulatory and antiviral functions of IL-27 in the placenta, with the goal of uncovering fundamental insights into cytokine communication that could improve maternal and neonatal outcomes. The project will run from September 1, 2024 to July 31, 2029.
Generated 3/4/25, 8:15 AM